Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening
Circulation · 05.05.2026 · 153 (18) · 1347-1349
DOI: 10.1161/circulationaha.125.077435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 05.05.2026. Verfasst von Roddy Walsh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Genomics Research Institute, City St. George's, University of London, London, UK (R.W.). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular and Genomics Research Institute, City St. George's, University of London, London, UK (R.W.).
- Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain (P.G.-P.).
- Centro Nacional de Investigacionees Cardiovasculares, Madrid, Spain (P.G.-P., J.P.O.).
- Centro de Investigación Biomédica en Red, Madrid, Spain (P.G.-P., J.P.O.).
ORCID-Profile: Roddy Walsh, Pablo Garcia-Pavia, Juan Pablo Ochoa
Zitieren
APA
Walsh, R., Garcia-Pavia, P., & Ochoa, J. P. (2026). Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening. Circulation, 153(18), 1347-1349. https://doi.org/10.1161/circulationaha.125.077435
Vancouver
Walsh R, Garcia-Pavia P, Ochoa JP. Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening. Circulation. 2026;153(18):1347-1349. doi:10.1161/circulationaha.125.077435
BibTeX
@article{Walsh2026,
author = {Walsh, Roddy and Garcia-Pavia, Pablo and Ochoa, Juan Pablo},
title = {Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening},
journal = {Circulation},
year = {2026},
volume = {153},
number = {18},
pages = {1347--1349},
doi = {10.1161/circulationaha.125.077435}
}
EUVIMED